Literature DB >> 10146994

Pitfalls in the interpretation of pharmacoeconomic studies.

N M Kaplan1.   

Abstract

Mesh：

Substances：

Year:  1992        PMID： 10146994     DOI： 10.2165/00019053-199201050-00001

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  9 in total

1.  Management of elderly patients with sustained hypertension.

Authors:  K Beard; C Bulpitt; H Mascie-Taylor; K O'Malley; P Sever; S Webb
Journal:  BMJ       Date:  1992-02-15

2.  Oregon's plan. Should it be approved?

Authors:  D M Eddy
Journal:  JAMA       Date:  1991-11-06       Impact factor: 56.272

3.  Cost-effectiveness of antihypertensive drugs. Fact or fancy?

Authors:  N M Kaplan
Journal:  Am J Hypertens       Date:  1991-05       Impact factor: 2.689

4.  The treatment of mild hypertension study. A randomized, placebo-controlled trial of a nutritional-hygienic regimen along with various drug monotherapies. The Treatment of Mild Hypertension Research Group.

Authors: 
Journal:  Arch Intern Med       Date:  1991-07

5.  Screening for hypertension.

Authors:  B Littenberg; A M Garber; H C Sox
Journal:  Ann Intern Med       Date:  1990-02-01       Impact factor: 25.391

6.  Long-term cost-effectiveness of various initial monotherapies for mild to moderate hypertension.

Authors:  J T Edelson; M C Weinstein; A N Tosteson; L Williams; T H Lee; L Goldman
Journal:  JAMA       Date:  1990-01-19       Impact factor: 56.272

7.  An economic evaluation of lovastatin for cholesterol lowering and coronary artery disease reduction.

Authors:  J W Hay; E H Wittels; A M Gotto
Journal:  Am J Cardiol       Date:  1991-04-15       Impact factor: 2.778

8.  The cost-effectiveness of treating mild-to-moderate hypertension: a reappraisal.

Authors:  I Kawachi; L A Malcolm
Journal:  J Hypertens       Date:  1991-03       Impact factor: 4.844

Review 9.  Controlled clinical trials of drug treatment for hypertension. A review.

Authors:  J A Cutler; S W MacMahon; C D Furberg
Journal:  Hypertension       Date:  1989-05       Impact factor: 10.190
  9 in total
  2 in total

1.  Cost-effectiveness analysis: obstacles to standardisation and its use in regulating pharmaceuticals.

Authors:  B R Luce
Journal:  Pharmacoeconomics       Date:  1993-01       Impact factor: 4.981

2.  A Facilitatory Effect of Perceptual Incongruity on Target-Source Matching in Pictorial Metaphors of Chinese Advertising: EEG Evidence.

Authors:  Shuo Cao; Yanzhang Wang; Huili Wang; Hongjun Chen; Guanghui Zhang; Ada Kritikos
Journal:  Adv Cogn Psychol       Date:  2020-01-29
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.